ThermoGenesis has acquired 2 companies. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
ThermoGenesis has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (50%) and medical products (50%).
2711 Citrus Road,
Rancho Cordova, California
95742
United States,
(916) 858-5100
www.thermogenesis.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2019-01-04 |
CARTXpress Bio, Inc. · Medical Products
, Germany · www.thermogenesis.com CARTXpress Bio, Inc. is a developer and commercialization of automated medical devices and technologies for cell-based therapies, including stem cell banking, point-of-care applications, and large-scale cell manufacturing of immunotherapy drugs, such as chimeric antigen receptor (CAR) T cells. |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
